Griseofulvin is NOT appropriate for treating tinea versicolor
Griseofulvin is explicitly contraindicated for tinea versicolor and should never be used for this condition. The FDA drug label clearly states that griseofulvin is "not effective" in tinea versicolor 1. This is a critical distinction that must be understood when considering antifungal therapy.
Why Griseofulvin Doesn't Work for Tinea Versicolor
The fundamental issue is organism-specific activity:
- Tinea versicolor is caused by Malassezia species (a yeast), not dermatophytes 2
- Griseofulvin only works against dermatophytes - specifically Trichophyton, Microsporum, and Epidermophyton species 1
- Griseofulvin's mechanism (inhibiting nucleic acid synthesis and fungal cell wall formation) is ineffective against Malassezia
What Griseofulvin IS Indicated For
According to FDA labeling, griseofulvin is approved for dermatophyte infections including 1:
- Tinea capitis (scalp ringworm)
- Tinea corporis (body ringworm)
- Tinea pedis (athlete's foot)
- Tinea cruris (jock itch)
- Tinea barbae (beard area)
- Tinea unguium (nail infections)
For tinea capitis specifically, griseofulvin demonstrates 88.5% response rates for Microsporum species and remains highly effective when dosed at 15-20 mg/kg/day for 6-8 weeks 3.
Correct Treatment for Tinea Versicolor
Use topical antifungals as first-line therapy 2:
- Zinc pyrithione
- Ketoconazole (topical)
- Terbinafine (topical)
For severe or recalcitrant cases, use oral azoles 2:
- Itraconazole (oral)
- Fluconazole (oral)
Critical caveat: Oral terbinafine is also ineffective for tinea versicolor, despite being effective for dermatophyte infections 2.
Common Pitfall to Avoid
Do not confuse "tinea versicolor" with other "tinea" infections. The name is misleading - tinea versicolor is NOT a dermatophyte infection despite the "tinea" nomenclature. All other tinea infections (capitis, corporis, pedis, etc.) are caused by dermatophytes and may respond to griseofulvin, but tinea versicolor will not.